Literature DB >> 21482953

Tonic seizures: a diagnostic clue of anti-LGI1 encephalitis?

Danielle M Andrade1, Peter Tai, Josep Dalmau, Richard Wennberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21482953      PMCID： PMC3090064          DOI： 10.1212/WNL.0b013e3182152808

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  5 in total

1.  Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series.

Authors:  Meizan Lai; Maartje G M Huijbers; Eric Lancaster; Francesc Graus; Luis Bataller; Rita Balice-Gordon; John K Cowell; Josep Dalmau
Journal:  Lancet Neurol       Date:  2010-06-28       Impact factor: 44.182

2.  Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody.

Authors:  M J Thieben; V A Lennon; B F Boeve; A J Aksamit; M Keegan; S Vernino
Journal:  Neurology       Date:  2004-04-13       Impact factor: 9.910

3.  Adult-onset drug-refractory seizure disorder associated with anti-voltage-gated potassium-channel antibody.

Authors:  Ramon F Barajas; D Eric Collins; Soonmee Cha; Michael D Geschwind
Journal:  Epilepsia       Date:  2009-09-22       Impact factor: 5.864

4.  Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis.

Authors:  Angela Vincent; Camilla Buckley; Jonathan M Schott; Ian Baker; Bonnie-Kate Dewar; Niels Detert; Linda Clover; Abigail Parkinson; Christian G Bien; Salah Omer; Bethan Lang; Martin N Rossor; Jackie Palace
Journal:  Brain       Date:  2004-02-11       Impact factor: 13.501

5.  Immunotherapy-responsive seizure-like episodes with potassium channel antibodies.

Authors:  S R Irani; C Buckley; A Vincent; O C Cockerell; P Rudge; M R Johnson; S Smith
Journal:  Neurology       Date:  2008-09-24       Impact factor: 9.910
  5 in total
  39 in total

Review 1.  Neuronal surface antibody-mediated autoimmune encephalitis.

Authors:  Jenny J Linnoila; Myrna R Rosenfeld; Josep Dalmau
Journal:  Semin Neurol       Date:  2014-11-04       Impact factor: 3.420

Review 2.  The utility of EEG, SSEP, and other neurophysiologic tools to guide neurocritical care.

Authors:  Eric S Rosenthal
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

Review 3.  Autoimmunity, seizures, and status epilepticus.

Authors:  Rebecca Davis; Josep Dalmau
Journal:  Epilepsia       Date:  2013-09       Impact factor: 5.864

Review 4.  Autoimmune encephalitis in children.

Authors:  Thaís Armangue; Mar Petit-Pedrol; Josep Dalmau
Journal:  J Child Neurol       Date:  2012-08-29       Impact factor: 1.987

Review 5.  Autoimmune encephalitis update.

Authors:  Josep Dalmau; Myrna R Rosenfeld
Journal:  Neuro Oncol       Date:  2014-03-16       Impact factor: 12.300

Review 6.  Autoimmune encephalitis as differential diagnosis of infectious encephalitis.

Authors:  Thaís Armangue; Frank Leypoldt; Josep Dalmau
Journal:  Curr Opin Neurol       Date:  2014-06       Impact factor: 5.710

Review 7.  Autoimmune encephalopathies.

Authors:  Frank Leypoldt; Thaís Armangue; Josep Dalmau
Journal:  Ann N Y Acad Sci       Date:  2014-10-14       Impact factor: 5.691

8.  Autoimmune Encephalitis.

Authors:  Frank Leypoldt; Klaus-Peter Wandinger; Christian G Bien; Josep Dalmau
Journal:  Eur Neurol Rev       Date:  2013

9.  Limbic encephalitis and related cortical syndromes.

Authors:  Ignacio Rubio-Agusti; Miguel Salavert; Luis Bataller
Journal:  Curr Treat Options Neurol       Date:  2013-04       Impact factor: 3.598

10.  Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies.

Authors:  Mar Petit-Pedrol; Thaís Armangue; Xiaoyu Peng; Luis Bataller; Tania Cellucci; Rebecca Davis; Lindsey McCracken; Eugenia Martinez-Hernandez; Warren P Mason; Michael C Kruer; David G Ritacco; Wolfgang Grisold; Brandon F Meaney; Carmen Alcalá; Peter Sillevis-Smitt; Maarten J Titulaer; Rita Balice-Gordon; Francesc Graus; Josep Dalmau
Journal:  Lancet Neurol       Date:  2014-01-22       Impact factor: 44.182
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.